Exploring pentoxifylline as an alternative treatment for dexamethasone in diabetic patients with COVID-19: a randomized controlled trial
Abstract Background Recent infectious disease outbreaks, notably COVID-19, have significantly affected society. Despite initial preventive measures and vaccination efforts, COVID-19 persist, requiring effective treatments. Commonly used corticosteroids face debate over their efficacy, with studies q...
Saved in:
| Main Authors: | Mohsen Gholinataj Jelodar, Farahnaz Hoseinzadeh, Samaneh Mirzaei, Zahra Falahati, Fatemeh Saghafi |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2025-07-01
|
| Series: | European Journal of Medical Research |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s40001-025-02678-1 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Clinical and imaging features of patients with COVID-19 in a double-center cohort study
by: Mohsen Gholinataj Jelodar, et al.
Published: (2024-03-01) -
Immunomodulatory and Antioxidant Effects of Pentoxifylline and Other Therapeutic Agents in The Management of Myocardial Injury
by: Asmaa Saeed, et al.
Published: (2023-12-01) -
Pentoxifylline in Dogs With Osteoarthritis: Comparative Treatment and Efficacy Analysis With Meloxicam
by: Kurtuluş Parlak, et al.
Published: (2025-07-01) -
Effect of pentoxifylline on endothelial dysfunction, oxidative stress and inflammatory markers in STEMI patients
by: Asmaa Saeed, et al.
Published: (2024-12-01) -
Oxidative Mechanism of Peyronie’s Disease and Effectiveness of Pentoxifylline in the Therapeutic Management: A Narrative Review
by: Gianni Paulis, et al.
Published: (2025-02-01)